Terns Pharmaceuticals, Inc.

TERN · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$161,439$79,926$143,235$47,699
Short-Term Investments$196,725$183,514$139,879$118,283
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$3,945$3,992$2,071$948
Total Curr. Assets$362,109$267,432$285,185$166,930
Property Plant & Equip (Net)$1,470$1,029$1,804$1,046
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$350$56$37$94
Total NC Assets$1,820$1,085$1,841$1,140
Other Assets$0$0$0$0
Total Assets$363,929$268,517$287,026$168,070
Liabilities
Payables$2,148$2,515$1,645$2,126
Short-Term Debt$428$603$661$0
Tax Payable$1,490$1,206$1,071$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$11,584$7,620$5,091$4,694
Total Curr. Liab.$15,650$11,944$8,468$6,820
LT Debt$919$0$544$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,490$1,206$1,071$947
Total NC Liab.$2,409$1,206$1,615$947
Other Liabilities$0$0$0$0
Cap. Leases$919$603$1,205$0
Total Liabilities$18,059$13,150$10,083$7,767
Equity
Pref Stock$0$0$0$0
Common Stock$9$6$5$3
Retained Earnings-$421,481-$332,628-$242,418-$182,073
AOCI-$279-$19-$822-$338
Other Equity$767,621$588,008$520,178$342,711
Total Equity$345,870$255,367$276,943$160,303
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$363,929$268,517$287,026$168,070
Net Debt-$160,092-$79,323-$142,030-$47,699